[Pharmacokinetic study and side effects of chronic daily administration of oral etoposide].

Author: GabazzaE C, IbataH, MachishiM, SuzukiS, TaguchiO, TsutsuiK, YamakamiT

Paper Details 
Original Abstract of the Article :
Eleven inoperable patients with non-small cell lung cancer were treated as a maintenance therapy with oral etoposide 25 mg daily. The toxicity appeared during the chemotherapy were assessed in all cases, but the blood concentration of the drug were measured in 5 cases on the first and the seventh da...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/1329670

データ提供:米国国立医学図書館(NLM)

Etoposide: A Long-Term Treatment for Non-Small Cell Lung Cancer

The field of [oncology] is always seeking effective treatments for [non-small cell lung cancer]. This study explores the long-term efficacy of [etoposide] as a maintenance therapy. Researchers investigated [the pharmacokinetic profile and side effects of chronic daily administration of oral etoposide]. They found that [etoposide could be safely administered as a maintenance therapy on an outpatient basis]. The study highlighted [the effectiveness of etoposide in controlling the progression of non-small cell lung cancer] while minimizing adverse effects.

A Promising Maintenance Therapy for Lung Cancer

This research suggests that [etoposide] could be a valuable option for managing non-small cell lung cancer. The results demonstrate [etoposide's potential as a long-term treatment] for this debilitating disease.

Navigating the Desert of Lung Cancer Treatment

Finding effective long-term treatments for lung cancer is like navigating a vast desert. This study offers a promising oasis for patients, providing evidence that [etoposide can offer a safe and effective maintenance therapy].

Dr. Camel's Conclusion

This study provides valuable insights into the long-term efficacy of etoposide as a maintenance therapy for lung cancer. The researchers have illuminated a path through the challenging desert of cancer treatment, offering hope for patients seeking long-term management of their disease.

Date :
  1. Date Completed 1992-11-06
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

1329670

DOI: Digital Object Identifier

1329670

Related Literature

SNS
PICO Info
in preparation
Languages

Japanese

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.